LDHA and non-small cell lung carcinoma: Glycolysis inhibition by 2-DG and oxamate or simultaneous silencing of LDHA and LDHB markedly reduced H3K18la levels, along with decreased KRT19 expression in NSCLC cells (Fig. 3I-L, Figure S3C).